The goal of this study is to collect preliminary clinical performance data focused on the usability aspects of the human - machine interaction, with focus on planning, navigation and application of automated laser tattoo removal. The study will enroll adult patients with monochrome dark tattoos. In addition to the data collected on the human-machine interaction, it will also collect other outcomes like pain during treatment, overall user and patient satisfaction, and adverse events. For the participants, treatment will follow standard procedures. In addition to this, they will be followed up after 30 days, to see if any complications occured.
Age range
18 Years – 84 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
•Visual Analogue Scale (VAS, 0-10 with 0 meaning it was impossible to use and 10 meaning it was very simple to use) for defining target region, region of therapy, clarity and degree of completion of projection of region of therapy on patient skin
Timeframe: Directly after treatment
•Visual Analogue Scale (VAS, 0-10 with 0 meaning it was impossible to use and 10 meaning it was very simple to use) for usefulness of indication of size of region of therapy
Timeframe: Directly after treatment
• Yes /No for laser path assessment (whether it was erratic or not)
Timeframe: Directly after treatment
• # for number of unintended interruptions
Timeframe: Directly after treatment